ASP Isotopes

ASP Isotopes Accounts Payable

The Accounts Payable of ASP Isotopes (ASPI) as of Nov 18, 2026 is 5.76 M USD. In the previous year, Accounts Payable was 1.02 M USD — a change of 463.45% (higher).

Accounts Payable

5.76 MUSD

YoY

463.45%

Last updated:

Accounts Payable of ASP Isotopes is 2025 5.76 M USD. Accounts Payable of ASP Isotopes was 2024 1.02 M USD. It decreases by 463.45% higher compared to the previous year.

The ASP Isotopes Accounts Payable history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Accounts Payable
Date
Accounts Payable
Jan 1, 2021
59,679.00 USD
Jan 1, 2022
1.35 M USD
Jan 1, 2023
1.11 M USD
Jan 1, 2024
1.02 M USD
Jan 1, 2025
5.76 M USD
The ASP Isotopes Accounts Payable history
YEARAccounts PayableYoY
5.76 MUSD+463.45%
1.02 MUSD-8.13%
1.11 MUSD-17.94%
1.35 MUSD+2,170.32%
59,679.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ASP Isotopes Stock analysis

What does ASP Isotopes do? ASP Isotopes, Inc. generates revenue through the development and commercialization of enriched isotopes using its Aerodynamic Separation Process (ASP technology). The company focuses on producing Carbon-14 (C-14), Molybdenum-100 (Mo-100), and Silicon-28 (Si-28) for specialized markets, with plans to expand into Uranium-235 (U-235) for the nuclear energy sector. Its subsidiaries, ASP Isotopes Guernsey Limited and Enriched Energy LLC, handle high-value isotope production and uranium development, respectively. The company licenses ASP technology from Klydon Proprietary Ltd for all isotope-related activities. The target customers for C-14, Mo-100, and Si-28 are highly specialized end markets requiring low-volume, high-value isotopes. Enriched Energy LLC specifically targets the nuclear energy market with uranium products. ASP Isotopes Guernsey Limited focuses on niche applications where isotope enrichment is critical, such as medical and industrial uses. The company’s revenue model relies on the sale of these enriched isotope products to specialized industries rather than mass-market consumers. ASP Isotopes, Inc. operates under a pre-commercial stage, meaning it is still developing its production capabilities and has not yet achieved full-scale commercialization. The company’s initial revenue streams will come from the sale of C-14, Mo-100, and Si-28, with future expansion into U-235 expected to diversify its product portfolio. The Aerodynamic Separation Process (ASP technology) is central to its business model, enabling the enrichment of natural isotopes into higher concentration products for specialized applications. ASP Isotopes is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ASP Isotopes stock

Accounts Payable of ASP Isotopes is 5.76 M USD in 2025.

Accounts Payable of ASP Isotopes changed from 1.02 M USD to 5.76 M USD, representing a 463.45% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Accounts Payable ASP Isotopes since 2006 – with annual values, charts, and detailed analysis.

Accounts payable represents money owed to suppliers for goods and services received. It is a key component of working capital management.

Accounts Payable's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Accounts Payable's ASP Isotopes historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — ASP Isotopes

All Key Metrics — ASP Isotopes